Friday, September 12, 2014

DBJ: 'FDA could be source of innovation, Hamburg says'

Quoting from the September 11th posting by Greg Avery:

"Hamburg’s vision is for the FDA to use that position to help researchers and companies make more effective new treatments and prove new medical advances more quickly, she said.

'We have a lot more to offer than has historically been appreciated,' said Hamburg, U.S. Commissioner of Food and Drugs since 2009. 'The regulator has a very different role than the innovator or the academic researcher, but we can be a very effective partner for both.'

It’s a theme Hamburg is stressing as U.S. Rep. Dianna DeGette, a Democrat representing Denver, and U.S. Rep. Fred Upton, R- Michigan, spearhead a bipartisan '21st Century Cures' initiative in Congress aimed at creating legislation to spur innovation and efficiency in medicine and health care. That could involve changes to FDA rules and budget.

Hamburg gave the closing keynote speech Wednesday at the Colorado BioScience Association’s annual BioWest convention. She had testified before DeGette and Upton in Washington D.C. earlier that same day."

Link to the Denver Business Journal

No comments:

Post a Comment